Skip to content

Clinical trials

Phase 2 Lennox Gastaut Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lennox Gastaut Syndrome Phase: Phase 2 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20182
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda2
Bright Minds Biosciences Pty Ltd1
KU Leuven1
Longboard Pharmaceuticals1
NeuroPace1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lennox Gastaut Syndrome6
Epilepsy5
Epilepsies, Myoclonic4
Seizures2
Tuberous Sclerosis2
Brain Diseases1
Central Nervous System Diseases1
Epilepsy, Absence1
Hypoxia-Ischemia, Brain1
Malformations of Cortical Development1

Trials

Showing 51 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.